Indirect comparison of efficacy of dupilumab versus mepolizumab and omalizumab for severe type 2 asthma

by Katrine Prætorius, Daniel P. Henriksen, Johannes M. Schmid, Pernille Printzlau, Lars Pedersen, Hanne Madsen, Ehm A. Andersson, Louise Klokker Madsen, Bo L. Chawes
Published 2021-08-01